Zota Health Care Ltd

Know More
NSEBSE

500.65-22.55 (-4.31%)

12:00 AM,8th Dec 2023

(%)

BSE : 538426

NSE : ZOTA

Sector : Others

ISIN Code : INE358U01012

  • NSE
  • BSE
  • 1D
  • 5D
  • 1M
  • 6M
  • 1Y
  • 2Y
  • 5Y
  • MAX

Market Cap (₹ Cr)

1294

Turnover (₹ Cr)

0.85

Volume (Shares)

169927

Face Value

10

52-WK High

532.90

52-WK High Date

08 Dec 2023

52-WK Low

251.00

52-WK Low Date

23 Dec 2022

All Time High

532.90

All Time High Date

08 Dec 2023

All Time Low

89.64

All Time Low Date

10 May 2017

Zota Health Care Ltd

Zota Health Care Limited is a renowned pharmaceutical company that manufactures markets and exports pharmaceutical ayurvedic nutraceutical and over-the-counter (OTC) products. The Company was incorporated in July 12 2000 and is based out of Surat Gujarat. The Company meets the requirements of millions of people by increasing access to high-quality affordable medicines for chronic illnesses including heart disease diabetes thyroid disease and others giving India's pharmaceutical industry a boost.The Company has three business verticals: Marketing-a traditional business vertical and driving business verticals - Exports and Retail harmacy Chain. Through its chain Davaindia the largest private-sector generic pharmacy chain the Company is making strong inroads into the generic retail pharmacy business. The Company's state-of-the-art manufacturing facility at Sachin SEZ serves customers in more than 30 countries. Davaindia is a retail generic pharmacy chain whose core value proposition is providing quality generic medicines at substantial discounts i.e. 30% to 90% to their branded equivalents. Davaindia focuses on private-label products in the medicinal OTC and ayurvedic categories with a greater emphasis on chronic therapies and ailments.The Marketing business vertical involves the direct distribution of generic drugs OTC products and other pharmaceutical products through the Company's distribution network across India. In domestic Marketing business the Company procures finished dosage forms (FDFs) from domestic formulation manufactures and then market them under its portfolio of brands. It has a set of manufacturing partners recognized by the WHO with a rigorous focus on product quality. With a portfolio of more than 3000 products in various categories such as generics OTC products allopathic ayurvedic etcetera the Company cater to a variety of ailments. Currently the Company has over 1050 distributors spread around the country. Instead of the Company directly engaging in sales distribution and promotion activities its distributors engage in ethical marketing or other sales distribution and promotion activities on their own. Instead it provide distributors directly with incentives to help them sell products more effectively.Secondly the exports business vertical started in 2010 following the establishment of formulations manufacturing facility in the Sachin SEZ. The Company is required to export products from this unit in accordance with the laws governing this SEZ. At present it has product approvals in 30 countries particularly in the semi-regulated and regulated markets in the African Asian CIS and Latin American countries. In this facility the Company make around 250 formulations for direct exports and contract manufacturing. . At present the Company has 253 dossiers approved across multiple countries and another 311 dossiers have been filed and are pending approval. It significantly increased efforts and investments towards product registration the results of which are now apparent in the form of product approvals and expansion of export operations. In the Retail Pharmacy Chain business vertical the Company operates a chain of pharmacy stores under the brand - Davaindia. Davaindia focuses only on private-label products in the medicinal OTC and ayurvedic categories with a greater emphasis on chronic therapies and ailments. This concept started with three pilot stores in 2017 and has been scaled up to become the largest private-sector generic pharmacy chain with more than 591 stores as of March 2021. Davaindia operates on a unique asset-light franchise model for majority stores. These stores are engaged in exclusive sales of Davaindia products with more than 95% of products being private-label. In all areas and media such as TV commercials printing digital & social media radio among others the Company has undertaken bold and aggressive marketing and promotion activities with the firm intention of creating top-of-the-mind brand recall for Davaindia. Davaindia - being a front-runner in private sector generic pharmacy has also assumed the responsibility to create awareness propagate virtues and debunk misconceptions about generic drugs. Marketing efforts are receiving very encouraging results from prospective franchisees and potential customers. The Company witnessed a substantial improvement in average wallet spend footfall at stores and the number of inquiries for new franchisees with aggressive marketing campaigns. The Company has started a series of promotions including TV and digital advertisements featuring Mr Kapil Dev. Mr Kapil Dev as an iconstands for integrity excellence and willpower the Company strongly feels he is the perfect fit for endorsing the culture and spirit of Davaindia and Zota Health Care Limited.

Zota Health Care Ltd - Key Fundamentals

PARAMETER VALUES
Market Cap (₹ Cr)

1294

EPS - TTM (₹) [S]

0.94

P/E Ratio (X) [S]

10.55

Face Value (₹) 10
Latest Dividend (%)10.00
Latest Dividend Date 22 Sep 2023
Dividend Yield (%) 0.19
Book Value Share (₹) [S]47.46
P/B Ratio (₹) [S]10.55
[*C] Consolidated [*S] Standalone

Funds Owing this Stock

Scheme Name Amount Invested ( ₹ Cr ) No Of Shares Net Asset (%)

Research Reports

Date BrokerActionPrices(Rs)Report
Data Not Found

Stock Strength

Today's Low/High

495.25

532.90

Week Low/High

452.20

533.00

Month Low/High

400.00

533.00

Year Low/High

251.00

533.00

All time Low/High

0.00

533.00

Share Price Returns

Period BSENSE SENSEXNIFTY
1 Week%8.81%3.473.46%
1 Month%17.95%7.467.85%
3 Month%18.32%4.845.80%
6 Month%63.64%11.1012.53%
1 Year%91.31%11.5912.68%
3 Year%252.69%53.1056.57%

Company Info

Company Information

Chairman & Non Executive Dir. : Ketankumar Zota

Managing Director : Moxesh Zota

Whole-time Director : Kamlesh Zota

Whole-time Director : Himanshu Zota

Whole-time Director : Manukant Zota

Independent Director : Varsaben Mehta

Independent Director : Saileshkumar Shah

Independent Director : Mahesh Prajapati

Company Secretary : Ashvin Variya

Registered Office: Zota House 2/896 Hira Modi St, Sagrampura,Surat,Gujarat-395002 Ph: 91-261-2331601

Email:info@zotahealthcare.com

URL:http://www.zotahealthcare.com